Using microarrays, we identified de novo copy number variations in the SHANK2 synaptic scaffolding gene in two unrelated individuals with autism-spectrum disorder (ASD) and mental retardation. DNA sequencing of SHANK2 in 396 individuals with ASD, 184 individuals with mental retardation and 659 unaffected individuals (controls) revealed additional variants that were specific to ASD and mental retardation cases, including a de novo nonsense mutation and seven rare inherited changes. Our findings further link common genes between ASD and intellectual disability.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Gene Expression Omnibus
Abrahams, B.S. & Geschwind, D.H. Nat. Rev. Genet. 9, 341–355 (2008).
Szatmari, P. et al. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B, 3–9 (2008).
Tarpey, P.S. et al. Nat. Genet. 41, 535–543 (2009).
Jamain, S. et al. Nat. Genet. 34, 27–29 (2003).
Durand, C.M. et al. Nat. Genet. 39, 25–27 (2007).
Moessner, R. et al. Am. J. Hum. Genet. 81, 1289–1297 (2007).
Szatmari, P. et al. Nat. Genet. 39, 319–328 (2007).
Marshall, C.R. et al. Am. J. Hum. Genet. 82, 477–488 (2008).
Weiss, L.A. et al. N. Engl. J. Med. 358, 667–675 (2008).
Cook, E.H. Jr. & Scherer, S.W. Nature 455, 919–923 (2008).
Fernandez, B.A. et al. J. Med. Genet. 47, 195–203 (2010).
Sheng, M. & Kim, E. J. Cell Sci. 113, 1851–1856 (2000).
Boeckers, T.M. et al. J. Neurosci. 19, 6506–6518 (1999).
Boeckers, T.M. et al. J. Neurochem. 92, 519–524 (2005).
Hayashi, M.K. et al. Cell 137, 159–171 (2009).
We gratefully thank E. Fenner, M. Fritsche and S. Peykov for sequencing and technical support, and we thank all the affected individuals' families for their cooperation. We thank A. Fiebig, A. Franke and S. Schreiber at POPGEN (University of Kiel, Kiel, Germany) and A. Stewart, R. McPherson and R. Roberts of the University of Ottawa Heart Institute (University of Ottawa, Ottawa, Canada) for generously providing population control microarray data. The international Autism Genome Project and Autism Speaks is also gratefully acknowledged for support. Funding was provided by the German Mental Retardation Network (MRNET), supported by the Federal Ministry of Education and Research, Germany, by the Deutsche Forschungsgesellschaft (DFG; SFB488) and the Medical Faculty of Heidelberg. S.B. was funded by a fellowship of CellNetworks–Cluster of Excellence (EXC81) and is a member of Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS). S.W.S. is supported by The Centre for Applied Genomics, Genome Canada and Ontario Genomics Institute, the Canadian Institutes for Health Research (CIHR), the Canadian Institute for Advanced Research (CIFAR), the McLaughlin Centre, the Canada Foundation for Innovation, the Ontario Ministry of Research and Innovation and the Hospital for Sick Children Foundation. S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children. G.A.R. is a member of CellNetworks–Cluster of Excellence (EXC81). Dedicated to Mrs. Elisabeth Berkel.
The authors declare no competing financial interests.
About this article
Cite this article
Berkel, S., Marshall, C., Weiss, B. et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42, 489–491 (2010) doi:10.1038/ng.589
Genes, Brain and Behavior (2019)
Shank Proteins Couple the Endocytic Zone to the Postsynaptic Density to Control Trafficking and Signaling of Metabotropic Glutamate Receptor 5
Cell Reports (2019)
Current Opinion in Structural Biology (2019)
Purification and mutagenesis studies of TANC1 ankyrin repeats domain provide clues to understand mis-sense variants from diseases
Biochemical and Biophysical Research Communications (2019)
Nature Neuroscience (2019)